Aggregation of RBC is a physiological property of blood which causes RBC to be arranged in rouleaux (22). The following processes are involved in the formation of RBC aggregates: 1) interaction of RBC and membrane deformation to increase the contact area; 2) formation of bridges between adjacent RBC by macromolecules such as fibrinogen, immunoglobulins, or high molecular weight dextran; 3) formation of a three-dimensional network of rouleaux (Fig. 1) . These processes require several seconds of contact between adjacent RBC and, therefore, occur Received November 30, 1983; accepted June 18, 1984. Requests for reprints should be addressed to 0. Linderkamp only during stasis or at low shear stresses (5, 22, 23) . ~t high shear stresses (about 3 dynes/cm2 or more), RBC aggregates are rapidly dispersed (23). Thus, RBC aggregation usually takes place only in the venous portion of the circulation where the blood flow rate is slow and the fluid shear stresses are low. RBC aggregation may occur in other sections of the circulation, however, under pathophysiological situations of reduced blood flow (i.e. shock). Conversely, increased RBC aggregation (e.g. as a result of high fibrinogen level) can cause lower blood flow rates, and this latter mechanism has been suggested as a possible factor in the pathogenesis of circulatory and thromboembolic complications in septicemia, pregnancy, diabetes, etc. (18, 20, 22) .
only during stasis or at low shear stresses (5, 22, 23) . ~t high shear stresses (about 3 dynes/cm2 or more), RBC aggregates are rapidly dispersed (23) . Thus, RBC aggregation usually takes place only in the venous portion of the circulation where the blood flow rate is slow and the fluid shear stresses are low. RBC aggregation may occur in other sections of the circulation, however, under pathophysiological situations of reduced blood flow (i.e. shock). Conversely, increased RBC aggregation (e.g. as a result of high fibrinogen level) can cause lower blood flow rates, and this latter mechanism has been suggested as a possible factor in the pathogenesis of circulatory and thromboembolic complications in septicemia, pregnancy, diabetes, etc. (18, 20, 22) .
In term neonates, the rate and the final extent of RBC aggregation are lower than in adults (7, 8, 24) . No information is available on RBC aggregation in preterm infants. In addition, it is unknown whether specific properties of neonatal RBC contribute to the decrease of aggregation. In this context, it is interesting to note that specific cellular factors are responsible for the impaired aggregability of both platelets and polymorphonuclear leukocytes in the neonate (9, 19) .
The present study was designed to measure the dynamics and the final extent of (in vitro) RBC aggregation of neonates with gestational ages of 24 to 41 weeks. Furthermore, we determined the isolated influence of plasma and of RBC on the aggregation process by suspending RBC from one adult donor in the plasma samples of the neonates and by suspending the RBC from the neonates in an aggregating dextran solution and in plasma from adults.
MATERIALS AND METHODS
Placental blood samples from seven preterm infants with GA of 24 to 28 wk and BW of 690 to 990 g, eight preterm infants with GA of 29 to 34 wk and BW of 1080 to 2140 g, and 10 healthy full term neonates with GA of 38 to 41 wk and BW of 2900 to 3570 g were studied with the approval of the University of Southern California Human Subjects Research Committee. Infants with malformations, erythroblastosis, diabetic mothers, hemorrhage, and intra-uterine asphyxia, and those delivered by cesarean section were excluded, as were twins and infants with a high risk of infection. All infants had birth weights less than the 90th and more than the 10th percentile for gestational age.
In the 25 neonates, 10 ml of placental blood were collected from the cord into heparin (5 IU/ml) immediately after cord severage prior to delivery of the placenta. Adult blood samples were collected from 13 healthy laboratory personnel via venipuncture into heparin. All measurements were made at room temperature (22 f l o C) within 4 hr after collection. RBC were isolated by centrifugation at 2000xg for 10 min and, via gentle aspiration, the plasma was removed and the buffy coat discarded. The cells were washed once via centrifugation-aspiration in an isotonic PBS (0.03 M KH2P04 + Na2HP04; 290 mosm/kg; pH 7.42 at 25" C). Following this wash, four different RBC suspensions (hematocrit, 45%) were prepared. 1) RBC were resuspended in their original plasma. 2) RBC from one of the adult donors (blood type Of) were resuspended in each plasma sample from both the neonates and the adults in order to evaluate the specific role of adult versus fetal plasma proteins in the aggregation process. 3) RBC from each donor were resuspended in a strongly aggregating (23) 1 % dextran-PBS solution (500,000 molecular weight, T-500, lot FR 13748, Pharmacia Co., Uppsala, Sweden); the pH and osmolality of this dextran-PBS solution were measured to be 7.42 and 291 mosm/kg. These suspensions were studied in order to evaluate the specific role of RBC in the aggregation process. 4) RBC from 10 neonates were resuspended in plasma from adults with the same blood type ( 0 or A, respectively).
Rate and extent of RBC aggregation were studied using the light transmission method of Schmid-Schonbein and co-workers (22, 23) . This technique is based on the increase of light transmission through a RBC suspension which occurs when individual RBC aggregate into rouleaux during blood stasis. The gaps in the suspending medium which develop between the cell aggregates produce the increased light transmission (Figs. 1 and 2) .
Light transmission studies were done using a counter-rotating cone-plate rheoscope system (Effenberger, Munich, Federal Republic of Germany) consisting of a transparent glass plate and a transparent, plastic 1.5" cone. The cone and the plate are rotated, in opposite directions, by a Servo-controlled DC motor. The variation of their rotational speed allows the shear rate in the 30-pm gap between the cone and the plate to be changed. The rheoscope is mounted on the stage of an inverted microscope (Leitz Diavert, Leitz, Wetzlar, Germany) and the optical path is illuminated, at a wavelength of 600 nm, by a low voltage bulb powered by a stabilized DC power supply. The light source of the microscope passes through the cone-plate portion of the rheoscope to a photocell which replaces the usual eyepiece. The 9/n LIGHT TRANSMISSION Fig. 2 . Change in light transmission in the rheoscope after sudden stop of the motor. 0% indicates no light transmission (i.e. light source switched off); 100% indicates maximum light transmission (i.e. without sample). RBC from a preterm infant, a term neonate, and an adult were suspended in autologous plasma. RBC from the preterm infant suspended in dextran are also shown. Note the initial drop of light transmission. In the preterm infant, there was no RBC aggregation during 100 s of blood stasis. The term infant showed little RBC aggregation. In dextran, RBC aggregation was very strong.
photocell voltage is amplified and recorded on a strip chart recorder (Linear Instruments Co., Irvine, CA).
After placing 20 p1 of the cell suspension in the gap, the suspension is sheared at 460 s-' for 30 s in order to disperse all RBC aggregates. The drive motor is then instantly stopped and the light transmission abruptly drops due to a transient state of random cellular orientation (Fig. 2) . Following this rapid drop, the transmission increases with the time at a rate proportional to the rate of RBC aggregation (i.e. at a rate proportional to the formation of cell-free liquid gaps between aggregates). In cases of strong RBC aggregation, a steep initial rise in light transmis-sion is followed by a slow increase. In cases of poor RBC aggregation, the initial steep rise is missing (Fig. 2) .
In order to obtain indices of the rate and final extent of RBC aggregation, two evaluation methods were used (22) . 1) The initial steep rise in light transmission was recorded using a relatively rapid paper speed of 40 cm/min. This portion of the curve was differentiated and the resulting data were plotted semilogarithmically as In (dV/dt) versus time (t). The slope of the resulting straight line was obtained by least squares linear regression (3) and the AHT, (in s) was calculated from this slope as: AHT, = -In 2/slope. Thus, AHT, describes the initial steep rise in RBC aggregation immediately after the beginning of blood stasis. Note that AHTI cannot be determined in cases with poor RBC aggregation (Fig. 2) . In samples with sufficient RBC aggregation, AHTI was determined in triplicate for each suspension and the mean value of these three measurements was used for each suspension; the coefficient of variation of these individual measurements was less than 10%.
2) Light transmission was recorded for 10 min using a slow paper speed of 4 cm/min so that both the overall rate and the final extent of RBC aggregation could be assessed. In these studies, 0 and 100% light transmission (i.e. minimum light transmission with light source switched off and maximum light transmission without sample) were calibrated, as shown in Fig.  2 . RBC aggregation was expressed as increase in RLT (i.e. difference between the minimum and subsequent light transmission through the sample). The maximum increase in RLT was assumed to occur after 10 min of stasis and was used to estimate the final extent of RBC aggregation (Fig. 3) . The time needed to reach 50% of the maximum increase in RLT was taken to indicate the overall rate of aggregation (AHT*).
Hence, four parameters were used to describe RBC aggregation (Table 1) : I) AHT, is derived from the initial rapid rise in RBC aggregation immediately after the beginning of blood stasis. It is in the order of a few seconds and describes the rate of initial aggregation. 2) AHT2 is derived from 10-min recordings of light transmission and describes the overall rate of RBC aggregation.
3) Increase in RLT is measured during 1 rnin of stasis. In adults, RBC aggregation nearly reaches the maximum after 1 min of stasis (Fig. 3) . 4) Increase in RLT is measured during 10 min of stasis. It indicates the maximum or final extent of RBC aggregation.
The hematocrits of RBC suspensions were determined using the microhematocrit technique. The values were not corrected for trapped plasma which is about 2% in full term neonates and adults (1 1). Solution osmolalities were measured by freezing point depression (Model 2007, Precision Systems, Sudbury, MA) and pH by a Radiometer Model PHM 71 system (Radiometer Co., Copenhagen, Denmark) operating at 25°C. Plasma fibrinogen concentrations were measured via a radial immunodiffusion technique (M-Partigen Fibrinogen Kit, Calbiochem-Behring Co., La Jolla, CA).
Analysis of variance was used to test for differences in measurements among the two groups of preterm infants, the full term neonates, and the adults (3). Regression analyses were utilized to determine overall correlations between fibrinogen and increase in relative light transmission. RESULTS 
TIME OF AGGREGATION min
The plasma fibrinogen levels and the aggregation results for the 25 neonates and the 13 adults are summarized in Table 1 . Figure 3 shows the rate of aggregation measured as an increase in light transmission in the rheoscope during 10 min of stasis (i.e. after sudden stoppage of the rheoscope motor). Examination of these results leads to the following observations. 1) The fibrinogen levels were significantly decreased in the whole group of neonates when compared to the adults. The smallest infants showed the lowest fibrinogen levels.
2) The aggregation half-time derived from the initial rapid increase in light transmission (AHT,) was significantly longer in the full term infants when compared to the adults. In the preterm infants, the slope was too flat for this evaluation (Fig. 2). 3) The time-dependent increase in light transmission during 10 min of stasis demonstrated markedly different RBC aggregation patterns (Fig. 3) ; after 1 rnin of stasis, there was almost no RBC aggregation in the most immature infants, little aggregation in the infants with 29 to 34 wk of gestation, marked aggregation in the full term neonates, and strong RBC aggregation in the adults. After 10 rnin of stasis, aggregation was evident in all infants but was clearly dependent on the gestational age of the infants as was the time needed to reach 50% of the 10-min value. 4) For the combined data from the 25 neonates and the 13 adults (Fig. 4) , there were significant exponential relationships between fibrinogen concentration and the aggregation data. Table 1 also presents aggregation results for RBC from one adult donor resuspended in the neonatal and adult plasma samples. There were no significant differences between the neonatal and the adult RBC when suspended in the plasma from the neonates. Thus, the origin of the RBC was without effect on the aggregating properties of the plasma samples.
The results of the RBC-dextran suspensions (Table 1) show that the RBC from all four groups aggregated equally in this medium. In 10 neonates, RBC were also resuspended in adult plasma samples with compatible blood types. These suspensions also show no significant differences between neonatal and adult RBC (Fig. 5) . Thus, different plasma properties, rather than different RBC properties, appear to be responsible for the decreased RBC aggregation noted in the neonates' plasma-RBC suspensions.
DISCUSSION
From the present data, we come to three major conclusions. 1) Both the speed and final extent of RBC aggregation are markedly lower in small preterm infants than in full term neonates and adults. 2) The weak RBC aggregation in small preterm infants is associated with low fibrinogen levels. 3) Exchange of the original plasma for adult plasma or for strongly aggregating dextran increases RBC aggregation in preterm infants to adult values.
Aggregation after lmin of stasis
In general, decreased RBC aggregation in the neonates correlated with lower fibrinogen levels (Fig. 4) . However, the preterm infants tended to have weaker RBC aggregation than the full term infants at similar fibrinogen levels. This was particularly evident after 1 min of stasis where RBC aggregation in the preterm infants approached zero at fibrinogen levels below 250 mg/dl while term neonates with similar fibrinogen levels still showed RBC aggregation (Fig. 4) . Thus, other factors appear to contribute to the weak RBC aggregation in preterm infants. In addition to fibrinogen, several other plasma proteins such as immunoglobulins, albumin, transfenin, and several clotting factors are lower in small preterm infants than in term neonates (2, 6, 9, 10, 17, 21) . Immunoglobulins, in particular, promote RBC aggregation because of their relatively large size although their effect is markedly less than that of fibrinogen (4) . Whether a special type of fetal fibrinogen (26) causes decreased RBC aggregation is unknown.
The aggregation tendency of RBC also depends on cellular properties such as the electrical charge of cell surface, RBC deformability, and cell geometry (4) . Electrical charge (16), deformability (14) , and shape (15) of neonatal and adult RBC are not different. This concurs with our finding that RBC from all donors showed similar aggregation when suspended in dextran or in plasma from adult donors ( Table 1, Fig. 5) . Thus, the specific properties of neonatal RBC (e.g. size, hemoglobin F) do not appear to affect aggregation.
An important effect of RBC aggregation is the steep increase in blood viscosity at low shear rates (4). Our aggregation data explain why this rise in blood viscosity with decreasing shear rate is markedly less in small preterm infants than in term neonates and adults (13) . Decreased RBC aggregation also explains the low erythrocyte sedimentation rate in newborn infants (1) .
The most striking conclusion from this study is that in most preterm infants with less than 29 weeks of gestation there is no RBC aggregation even after 1 min of stasis, whereas in term neonates and adults, RBC aggregates are formed within a few seconds of blood stasis. Implications are, however, at this point highly speculative. One of these implications could be that small preterm infants have a low risk of thromboembolic accidents. Another speculation is that cardiac arrest lasting 1 min will not cause noticeable RBC aggregation in small preterm infants, whereas in term neonates and adults, it would cause RBC aggregation in the entire circulation. It is unknown whether cardiac massage initiated after a short period of cardiac arrest is more successful if RBC aggregation is slow and weak because smaller shear forces are required to redisperse RBC aggregates.
Under physiological conditions in vivo, RBC aggregation takes place only in veins where shear conditions are low (5) . Thus, decreased RBC aggregation in preterm infants implies that a lower pressure gradient is required to drive blood through their veins. This may contribute to the peculiar circulation of preterm infants, who characteristically have low vascular pressures, low vascular resistances and high flow conditions (12, 25, 27) .
Besides these favorable hemorheological properties in preterm infants, there may be negative aspects as well. Because RBC aggregation plays a role in coagulation (1 8), weak RBC aggregation might contribute to the tendency of small preterm infants to develop intracranial hemorrhage. This speculation is supported by the finding of low plasma fibrinogen in many preterm infants with intracranial hemorrhage (17) . On the other hand, an increase in plasma fibrinogen and RBC aggregation might require raised arterial-capillary-venous driving pressures to maintain the microcirculation, thereby increasing the risk of cerebral vessel rupture.
We conclude from our data that RBC aggregation is markedly decreased in small preterm infants at birth when compared to term neonates and adults. We speculate that the weak RBC aggregation in preterm infants might play a role in maintaining the peculiarities of their circulation but also in their tendency to develop intracranial hemorrhage. An increase in fibrinogen and/ or other plasma proteins may increase RBC aggregation, thereby altering the characteristic blood flow conditions in preterm infants. Serial (prospective) hemorheological, circulatory, and coagulation studies on preterm infants are necessary to evaluate the role of RBC aggregation in postnatal complications.
